Stockscreener 앱 받기
3.74
1.58%
-0.06
시간 외 거래:
3.80
0.06
+1.60%
전일 마감가:
$3.80
열려 있는:
$3.8
하루 거래량:
24,922
Relative Volume:
0.47
시가총액:
$11.29M
수익:
$2.38M
순이익/손실:
$-12.40M
주가수익비율:
-0.5787
EPS:
-6.4626
순현금흐름:
$-18.68M
1주 성능:
-8.33%
1개월 성능:
-51.68%
6개월 성능:
-69.08%
1년 성능:
-80.92%
1일 변동 폭
$3.73
$3.93
1주일 범위
$3.50
$4.16
52주 변동 폭
$3.50
$22.20
Femasys Inc Stock (FEMY) Company Profile
명칭
Femasys Inc
전화
770-500-3910
주소
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
3.74 | 11.47M | 2.38M | -12.40M | -18.68M | -6.4626 |
ISRG
Intuitive Surgical Inc
|
405.97 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.19 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.61 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.61 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.43 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | Laidlaw | Buy |
Femasys Inc 주식(FEMY)의 최신 뉴스
Femasys Shareholders Approve Directors and Auditor at Meeting - TipRanks
Femasys (FEMY) investors back directors and KPMG auditor at 2026 meeting - Stock Titan
Femasys Regains Nasdaq Compliance and Expands Global Access to Innovative Fertility and Birth Control Solutions - Minichart
Femasys regains Nasdaq compliance with minimum bid price rule - Investing.com
Femasys Regains Compliance With Nasdaq Minimum Bid Price Rule - Moomoo
Femasys regains compliance with Nasdaq - TipRanks
Femasys regains Nasdaq minimum bid compliance after 1-for-20 reverse split - TradingView
Femasys Regains Nasdaq Compliance After Reverse Stock Split - TipRanks
Femasys (NASDAQ: FEMY) back in compliance with Nasdaq listing requirements - Stock Titan
Femasys regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com Canada
Femasys Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire
Femasys Inc (FEMY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Femasys Inc (FEMY) Institutional Confidence - TradingKey
FEMY Stock Price, Quote & Chart - ChartMill
Femasys, Inc. Stock Hits 52-Week Low at $4.50 Amid Challenges - MarketsMojo
Femasys, Inc. Stock Hits New 52-Week Low at $3.87 - MarketsMojo
Femasys Inc (FEMY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Femasys Inc (FEMY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Femasys Inc (FEMY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Femasys Inc (FEMY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Femasys, Inc. Stock Plummets to New 52-Week Low of $3.77 - MarketsMojo
Femasys Inc (FEMY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Femasys Inc (FEMY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Femasys Inc (FEMY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Femasys Inc. (FEMY) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive SurpriseEarnings Revision Upgrade - newsline.com
Femasys Inc.: Target Price Consensus and Analysts Recommendations | FEMY | US31447E2046 - marketscreener.com
Femasys Inc.: Performance & Quotes, FEMY Stock Price on Nasdaq Exchange - marketscreener.com
Femasys Inc.: Fundamental Analysis and Financial Ratings | FEMY | US31447E2046 - marketscreener.com
Femasys Inc.: Financial Data Forecasts Estimates and Expectations | FEMY | US31447E2046 - marketscreener.com
Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Beat Overshadowed by Revenue DisappointmentPost-Earnings Drift - dars.gov.et
FEMY Q1 2026 Earnings: EPS Surprises to the Upside as Narrower Loss Drives Stock HigherBalance Sheet Strength - newsline.com
Femasys Inc. (FEMY) Edges Higher as Stock Tests Key Resistance LevelsWMA Signal - newsline.com
Femasys, Inc. Hits New 52-Week Low at $5.08 Amid Market Challenges - MarketsMojo
Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Surprises to the Upside Despite Stock DeclineEstimate Dispersion - newsline.com
Femasys Inc. (FEMY) Shares Decline 14% as Price Tests Support Near $0.29Dark Pool Prints - newsline.com
Femasys Announces 1-for-20 Reverse Stock Split Implementation - The Globe and Mail
Femasys (NASDAQ: FEMY) implements 1-for-20 reverse stock split - Stock Titan
Femasys (FEMY) Slides 2.96% as Shares Test Key Support LevelVolume Spike Alerts - newsline.com
Femasys Announces 1-for-20 Reverse Stock Split Initiative - TipRanks
Femasys to implement 1-for-20 reverse stock split; trading symbol FEMY unchanged - TradingView
Reverse split will consolidate Femasys (NASDAQ: FEMY) common shares 20-to-1 - Stock Titan
Femasys, Inc. Financial Disclosures & SEC Filings - TradingView
Femasys Inc. (FEMY) Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline Amid Revenue UncertaintyRevenue Growth Report - newsline.com
FEMY Technical Analysis & Stock Price Forecast - Intellectia AI
Femasys Inc. (FEMY) Edges Higher as Key Support Holds at $0.37Technical Analysis Picks - The Legal Advocate
Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Beat Drives 29.85% Stock SurgeMid-Term Outlook - newsline.com
Femasys Analyst Ratings and Price Targets | NASDAQ:FEMY - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
FEMY Technical Analysis | Trend, Signals & Chart Patterns | FEMASYS INC (NASDAQ:FEMY) - ChartMill
Maxim Group Maintains Femasys(FEMY.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter - Sahm
Femasys Inc (FEMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.52%
자본화:
|
볼륨(24시간):